The Food and Drug Administration (FDA) has granted emergency use authority to Covaxin and Janssen vaccines.
FDA Director General Eric Domingo confirmed the news Tuesday, April 20.
Belgian drugmaker Janssen Pharmaceuticals filed an EUA application for its coronavirus disease (COVID-19) vaccine with the FDA on March 31.
The Indian pharmaceutical company, Bharat Biotech sought EUA from the FDA for Covaxin in January.
Last month, the FDA has granted an EUA to the Sputnik V vaccine of Russia’s Gamaleya Research Institute.
Gamaleya became the fourth drugmaker to be granted an EUA for their COVID-19 vaccine after Pfizer-BioNTech, AstraZeneca, and Sinovac.